Stay updated with breaking news from Patrickj Haley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Banco Santander S.A. purchased a new stake in Exelixis, Inc. (NASDAQ:EXEL – Free Report) during the 3rd quarter, Holdings Channel.com reports. The fund purchased 70,081 shares of the biotechnology company’s stock, valued at approximately $1,531,000. Other hedge funds also recently added to or reduced their stakes in the company. Fifth Third Bancorp increased its stake […]
Costello Asset Management INC lessened its position in shares of Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 43.0% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,920 shares of the biotechnology company’s stock after selling 2,205 shares during the period. Costello Asset Management INC’s […]
South Dakota Investment Council decreased its position in Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 1.9% during the 3rd quarter, Holdings Channel reports. The firm owned 183,758 shares of the biotechnology company’s stock after selling 3,500 shares during the quarter. South Dakota Investment Council’s holdings in Exelixis were worth $4,015,000 at the end of the […]
Exelixis (NASDAQ:EXEL – Get Free Report) had its price objective upped by analysts at Barclays from $24.00 to $25.00 in a research note issued on Tuesday, Benzinga reports. The firm presently has an “overweight” rating on the biotechnology company’s stock. Barclays‘s price target points to a potential upside of 14.21% from the stock’s current price. […]
Exelixis (NASDAQ:EXEL – Get Free Report) had its price objective boosted by research analysts at Barclays from $24.00 to $25.00 in a research note issued to investors on Tuesday, Benzinga reports. The brokerage presently has an “overweight” rating on the biotechnology company’s stock. Barclays‘s target price suggests a potential upside of 14.21% from the stock’s […]